 |
| Shane McDevitt |
Imre Health has recruited Digitas Health's Shane McDevitt as director of its medical and scientific affairs unit.
As medical editor at Digitas Health, McDevitt specialized in oncology brands. He will lead a team responsible for new therapies across the pharmaceutical, biotech and biopharmaceutical categories, while integrating medical and scientific savvy into existing practices.
Imre, which handles clients such as AstraZeneca, GlaxoSmithKline, Pfizer, Bausch Health and EQRx, ranked No. 8 on O'Dwyer's 2020 rankings of independent healthcare firms with fees of $21M.
Jeff Smokler, President of Imre Health, said his goal is to build a new agency model, where medicine and science sit among—rather than adjacent to—the integrated suite of strategic and creative services the agency delivers.
The firm added Josh Simon as VP-social health marketing earlier this year. He joined from AstraZeneca.
Imre has offices in Baltimore, Philadelphia, New York and Los Angeles.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
